Used primarily in the treatment of overactive bladder (OAB), this compound helps manage symptoms such as urinary urgency, frequent urination, and urge incontinence. It works by selectively activating beta-3 adrenergic receptors in the bladder, leading to relaxation of the detrusor muscle during the bladder filling phase. This action increases bladder capacity and reduces involuntary contractions, thereby improving patient comfort and quality of life. Due to its targeted mechanism, it offers an alternative to anticholinergic therapies, especially for patients who experience dry mouth, constipation, or other anticholinergic side effects.